Form 8-K - Current report:
SEC Accession No. 0000950170-24-090715
Filing Date
2024-08-05
Accepted
2024-08-05 16:04:45
Documents
11
Period of Report
2024-08-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mura-20240801.htm   iXBRL 8-K 44511
  Complete submission text file 0000950170-24-090715.txt   161886

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mura-20240801.xsd EX-101.SCH 28023
13 EXTRACTED XBRL INSTANCE DOCUMENT mura-20240801_htm.xml XML 4682
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Filer) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41837 | Film No.: 241174686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)